Gene polymorphisms and pharmacogenetics in rheumatoid arthritis

被引：5

作者：

Rego-Perez, Ignacio ^{[1
]}

Fernandez-Moreno, Mercedes ^{[1
]}

Carreira-Garcia, Vanessa ^{[1
]}

Blanco, Francisco J. ^{[1
]}

机构：

[1] INIBIC, Lab Invest, Div Reumatol, Unidad Invest Envejecimiento Osteoarticular, La Coruna, Spain

来源：

REUMATOLOGIA CLINICA | 2009年 / 5卷 / 06期

关键词：

Pharmacogenetics; Pharmacogenomics; Rheumatoid arthritis; Tumor necrosis factor; Interleukin-1; Cytokines; Gene polymorphisms;

D O I：

10.1016/j.reuma.2008.12.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Rheumatoid arthritis (RA) is a systemic, chronic, and inflammatory disease of unknown aetiology with a genetic predisposition. The advent of new biological agents, as well as the more traditional disease-modifying anti rheumatic drugs, has resulted in highly efficient therapies for reducing the symptoms and signs of RA; however, not all patients show the same level of response regarding disease progression to these therapies. These variations suggest that RA patients may have different genetic regulatory mechanisms. The extensive polymorphisms revealed in non-coding gene-regulatory regions in the immune system, as well as genetic variations in drug-metabolizing enzymes, suggest that this type of variation is of functional and evolutionary importance and may provide clues for developing new therapeutic strategies. Pharmacogenetics is a rapidly advancing area of research that holds the promise that therapies will soon be tailored to an individual patient's genetic profile.. Chronic and severe forms of gout are frequently wrongly evaluated from the clinical standpoint. (C) 2008 Elsevier Espana, S.L. All rights reserved.

引用

页码：268 / 279

页数：12

共 113 条

[1] TNF-α gene 1031 T/C polymorphism in Turkish patients with Behcet's disease [J].

Akman, A. ;

Sallakci, N. ;

Coskun, M. ;

Bacanli, A. ;

Yavuzer, U. ;

Alpsoy, E. ;

Yegin, O. .

BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (02) :350-356

[2]

[Anonymous], 2002, PHARMACOGENETICS, V12, P183

[3] THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].

ARNETT, FC ;

EDWORTHY, SM ;

BLOCH, DA ;

MCSHANE, DJ ;

FRIES, JF ;

COOPER, NS ;

HEALEY, LA ;

KAPLAN, SR ;

LIANG, MH ;

LUTHRA, HS ;

MEDSGER, TA ;

MITCHELL, DM ;

NEUSTADT, DH ;

PINALS, RS ;

SCHALLER, JG ;

SHARP, JT ;

WILDER, RL ;

HUNDER, GG .

ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324

[4] Disease activity and risk of lymphoma in patients with rheumatoid arthritis:: nested case-control study [J].

Baecklund, E ;

Ekbom, A ;

Sparén, P ;

Feltelius, N ;

Klareskog, L .

BRITISH MEDICAL JOURNAL, 1998, 317 (7152) :180-181

[5] Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene [J].

Berkun, Y ;

Levartovsky, D ;

Rubinow, A ;

Orbach, H ;

Aamar, S ;

Grenader, T ;

Abou Atta, I ;

Mevorach, D ;

Friedman, G ;

Ben-Yehuda, A .

ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (10) :1227-1231

[6] Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease [J].

Bouma, G ;

Crusius, JBA ;

Pool, MO ;

Kolkman, JJ ;

VonBlomberg, BME ;

Kostense, PJ ;

Giphart, MJ ;

Schreuder, GMT ;

Meuwissen, SGM ;

Pena, AS .

SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1996, 43 (04) :456-463

[7] Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in Multiple Sclerosis and it's influence on the regulation of TNF-alpha production [J].

Braun, N ;

Michel, U ;

Ernst, BP ;

Metzner, R ;

Bitsch, A ;

Weber, F ;

Rieckmann, P .

NEUROSCIENCE LETTERS, 1996, 215 (02) :75-78

[8]

BRENNAN FM, 1992, BRIT J RHEUMATOL, V31, P293

[9]

Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.3.CO

[10]

2-U

← 1 2 3 4 5 6 7 8 9 10 →